Melnick J L
Bull World Health Organ. 1989;67(2):105-12.
The present status of vaccination for controlling viral diseases is reviewed, and the needs and directions for future investigations are discussed. A survey of viral vaccines now in use has shown that knowledge about the viral agents and about the hosts' responses to infection was essential for their development. The steps needed to demonstrate the efficacy and safety of a viral vaccine are summarized; the final requirement for a successful vaccine is that it be administered in proper dosage and potency to the target populations. After general remarks on the proper use of current vaccines there follows an overview of various developments in creating new vaccines, along with the predicted time-frames for their coming into general use. Topics considered include vaccines to be administered locally at the portal of entry, subunit vaccines, viruses attenuated by genetic manipulation, use of viral vectors, vaccines developed by means of recombinant DNA, synthetic peptides, and anti-idiotype vaccines, as well as new vaccines being developed by more conventional methods.
本文回顾了控制病毒性疾病的疫苗接种现状,并讨论了未来研究的需求和方向。对目前正在使用的病毒疫苗的一项调查表明,有关病毒病原体以及宿主对感染反应的知识对于疫苗的研发至关重要。总结了证明病毒疫苗有效性和安全性所需的步骤;成功疫苗的最终要求是要以适当的剂量和效力施用于目标人群。在对当前疫苗的正确使用进行一般性评论之后,概述了新型疫苗研发的各种进展以及预计其普遍使用的时间框架。所考虑的主题包括在进入门户局部施用的疫苗、亚单位疫苗、通过基因操作减毒的病毒、病毒载体的使用、通过重组DNA、合成肽和抗独特型疫苗研发的疫苗,以及通过更传统方法研发的新型疫苗。